These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31941862)

  • 1. [Liver fibrosis:underlying mechanisms and clinical implication].
    Inagaki Y
    Nihon Shokakibyo Gakkai Zasshi; 2020; 117(1):9-19. PubMed ID: 31941862
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of liver cirrhosis: current evidence and expectations.
    Jung YK; Yim HJ
    Korean J Intern Med; 2017 Mar; 32(2):213-228. PubMed ID: 28171717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversibility of hepatic fibrosis].
    van der Meer AJ; Sonneveld M; Schouten JN; Janssen HL
    Ned Tijdschr Geneeskd; 2014; 158():A6790. PubMed ID: 24594125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhosis--can we reverse hepatic fibrosis?
    Tangkijvanich P; Yee HF
    Eur J Surg Suppl; 2002; (587):100-12. PubMed ID: 16144208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Present situation on non-invasive assessment of liver fibrosis/cirrhosis].
    Zhang QD; Lu LG
    Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):325-327. PubMed ID: 29996197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.
    Fernández-Ramos D; Fernández-Tussy P; Lopitz-Otsoa F; Gutiérrez-de-Juan V; Navasa N; Barbier-Torres L; Zubiete-Franco I; Simón J; Fernández AF; Arbelaiz A; Aransay AM; Lavín JL; Beraza N; Perugorria MJ; Banales JM; Villa E; Fraga MF; Anguita J; Avila MA; Berasain C; Iruzibieta P; Crespo J; Lu SC; Varela-Rey M; Mato JM; Delgado TC; Martínez-Chantar ML
    Cell Death Dis; 2018 Sep; 9(10):958. PubMed ID: 30237481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological evaluation of liver fibrosis and cirrhosis regression.
    Lo RC; Kim H
    Clin Mol Hepatol; 2017 Dec; 23(4):302-307. PubMed ID: 29281870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrosis/cirrhosis after orthotopic liver transplantation.
    Tabatabai L; Lewis WD; Gordon F; Jenkins R; Khettry U
    Hum Pathol; 1999 Jan; 30(1):39-47. PubMed ID: 9923925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis.
    Cheung KJ; Libbrecht L; Tilleman K; Deforce D; Colle I; Van Vlierberghe H
    Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1066-73. PubMed ID: 20186066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging therapies for liver fibrosis.
    Fowell AJ; Iredale JP
    Dig Dis; 2006; 24(1-2):174-83. PubMed ID: 16699275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved.
    Guyot C; Lepreux S; Combe C; Doudnikoff E; Bioulac-Sage P; Balabaud C; Desmoulière A
    Int J Biochem Cell Biol; 2006 Feb; 38(2):135-51. PubMed ID: 16257564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on cirrhosis of the liver. IV. The relations between the mortality from liver cirrhosis and the mortality from alcoholism, and between the mortality from liver cirrhosis and alcoholic consumption.
    NAKAMURA T; NAKAMURA S; KAWAMURA E; KANEKO T; SUGAWARA K; KATAKURA Y; ISONO T; SUZUKI I
    Tohoku J Exp Med; 1958 Apr; 67(4):365-71. PubMed ID: 13581054
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of liver fibrosis: From fiction to reality.
    Zoubek ME; Trautwein C; Strnad P
    Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):129-141. PubMed ID: 28624101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis.
    Wang JN; Li L; Li LY; Yan Q; Li J; Xu T
    Gene; 2018 Oct; 674():57-69. PubMed ID: 29944952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Increased production of interleukin-1 by macrophage from the patients with chronic liver disease and its implication for liver fibrosis].
    Koda K; Niitsu Y; Bunya M; Ito N; Sasagawa Y; Owada M; Morita K; Kohgo Y; Urushizaki I
    Nihon Shokakibyo Gakkai Zasshi; 1985 Jun; 82(6):1527-32. PubMed ID: 3877192
    [No Abstract]   [Full Text] [Related]  

  • 16. Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.
    Vela D
    Mol Med; 2018 Mar; 24(1):5. PubMed ID: 30134796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2001; (3):CD002148. PubMed ID: 11687017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of clinical variables and liver histology for development of fibrosis and cirrhosis in autoimmune hepatitis.
    Puustinen L; Boyd S; Mustonen H; Arkkila P; Arola J; Färkkilä M
    Scand J Gastroenterol; 2017 Mar; 52(3):321-327. PubMed ID: 27846740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
    Vilar-Gomez E; Calzadilla-Bertot L; Wai-Sun Wong V; Castellanos M; Aller-de la Fuente R; Metwally M; Eslam M; Gonzalez-Fabian L; Alvarez-Quiñones Sanz M; Conde-Martin AF; De Boer B; McLeod D; Hung Chan AW; Chalasani N; George J; Adams LA; Romero-Gomez M
    Gastroenterology; 2018 Aug; 155(2):443-457.e17. PubMed ID: 29733831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic fibrosis: physiopathology and biological diagnosis].
    Housset C; Guéchot J
    Pathol Biol (Paris); 1999 Nov; 47(9):886-94. PubMed ID: 10609268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.